Alerts will be sent to your verified email
Verify Email
OXYGENTAPH
|
Oxygenta Pharma
|
Accretion Nutraveda
|
Bio Medica Labs.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
16.56 % | 77.09 % | 43.58 % |
|
5yr average Equity Multiplier
|
-1.71 | 7.25 | 4.59 |
|
5yr Average Asset Turnover Ratio
|
1.26 | 1.09 | 0.9 |
|
5yr Avg Net Profit Margin
|
-10.07 % | 14.14 % | 14.7 % |
|
Price to Book
|
0.0 | 0.0 | 0.0 |
|
P/E
|
0.0 | 36.96 | 18.5 |
|
5yr Avg Cash Conversion Cycle
|
-21.7 Days | 88.82 Days | 34.88 Days |
|
Inventory Days
|
80.38 Days | 125.44 Days | 114.83 Days |
|
Days Receivable
|
20.8 Days | 40.1 Days | 30.75 Days |
|
Days Payable
|
154.17 Days | 182.51 Days | 279.97 Days |
|
5yr Average Interest Coverage Ratio
|
-3.16 | 5.76 | 5.69 |
|
5yr Avg ROCE
|
-3.19 % | 50.7 % | 39.6 % |
|
5yr Avg Operating Profit Margin
|
-9.3 % | 23.04 % | 29.22 % |
|
5 yr average Debt to Equity
|
-1.91 | 3.41 | 2.36 |
|
5yr CAGR Net Profit
|
n/a | 56.28 % | 96.99 % |
|
5yr Average Return on Assets
|
-6.87 % | 16.23 % | 13.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
56.54 % | 73.48 % | n/a |
|
Share Pledged by Promoters
|
0.0 | 0.0 | n/a |
|
Change in Promoter Holding (3 Yrs)
|
47.55 % | 73.48 % | n/a |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.04 % | 0.0 | n/a |
|
Oxygenta Pharma
|
Accretion Nutraveda
|
Bio Medica Labs.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|